A Physiologically Based Pharmacokinetic and Drug-Drug Interaction Model for the CB2 Agonist Lenabasum

Fu, Q; Jones, HM; Sun, G; Atamas, SP

Fu, Q (corresponding author), Corbus Pharmaceut Inc, 500 River Ridge Dr, Norwood, MA 02062 USA.

EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2021; 46 (4): 513

Abstract

Background and Objectives Lenabasum is a synthetic agonist of the cannabinoid receptor type 2 (CB2) with anti-inflammatory and antifibrotic properties......

Full Text Link